ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 109451 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 109451; 2) Community: the network communities that were significantly associated with the response to NSC 109451; 3) Molecule: the relationships between components within communities and NSC 109451; 4) MDR: the compounds that were significantly associated with the NSC 109451.

NSC Compound Enrichment Correlation
NSC 755442 Null 0.0434721470609156 0.12527176
NSC 762901 trans-4-{4-[3-(4-chloro-3-trifluoromethyl-phenyl)-ureido]-cyclohexyloxy}-pyridine-2-carboxylic acid methylamide 0.0434721470609156 -0.22075163
NSC 87864 N-Salicylidene-N-salicyloylhydrazine 0.0434721470609156 0.25634864
NSC 9594 Safranin bluish 0.0434721470609156 -0.015118907
NSC 100071 component of Halotex 0.0446159312763229 0.05504082
NSC 123463 Ethanesulfonic acid, compd. with 4-[3-[p-(4,6-diamino-2,2-dimethyl-s-triazin-1(2H)-yl)benzyl]ureido]-o-toluenesulfonyl fluoride (1:1) (8CI) 0.0446159312763229 -0.36428343
NSC 150862 BLEOMYCIN FRACTION BLM-HPE 0.0446159312763229 0.24680176
NSC 155693 6H-Pyrido[4,3-b]carbazolium, 9-methoxy-2,5,11-trimethyl-,iodide 0.0446159312763229 0.12143354
NSC 175633 4(1H)-Quinazolinone, 2-(2-chlorophenyl)-2,3-dihydro- 0.0446159312763229 -0.25064842
NSC 176503 Fastigilin B 0.0446159312763229 -0.15754881
Total:114  Current:92    [First] [Prev] [Next] [Last]